Filing Details

Accession Number:
0001181431-14-020646
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-05-21 17:45:42
Reporting Period:
2014-05-19
Filing Date:
2014-05-21
Accepted Time:
2014-05-21 17:45:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1492426 Horizon Pharma Inc. HZNP Pharmaceutical Preparations (2834) 272179987
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1523672 N Todd Smith C/O Horizon Pharma, Inc.
520 Lake Cook Road, Suite 520
Deerfield IL 60015
Evp & Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-05-19 10,159 $12.94 44,552 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Reflects shares of common stock surrendered via open market sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in December 2012, in order to satisfy certain tax withholding obligations.
  2. The shares were sold in three block trades at prices ranging from $12.92 to $12.95, and the price reported in the table reflects the weighted average sale price for such block trades. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  3. Includes 11,975 shares of the Company's common stock acquired pursuant to an employee stock purchase program.